WY
William D Young
Director

William D Young insider trades: Vertex Pharmaceuticals Inc / Ma (VRTX) stock buys and sales

Director, Vertex Pharmaceuticals Inc / Ma Last trade Jan 2, 2020 55 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2005
9
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

and 3 more companies

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 2, 2020VRTX↓ Sell$4.4M
Dec 30, 2019VRTX↓ Sell$6.6M
Mar 7, 2011THRX↓ Sell$120K
Feb 18, 2011THRX↓ Sell$125K
Dec 10, 2010THRX↓ Sell$143K
May 9, 2008MGRM↑ Buy$106K
Aug 5, 2005VLGC↑ Buy$59K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VRTX insiders

Open-market trades in the last 12 months

About William D Young's insider trades

William D Young is a director at Vertex Pharmaceuticals Inc / Ma (VRTX). Since Aug 5, 2005, William has reported 2 open-market purchases worth $165K and 5 sales worth $11.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (46 filings), option exercises (7 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.